SCHEMBL9715487

SCHEMBL9715487

CCOC(=O)CC(C#N)c1ccccc1F

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
NLRP3 Q96P20 3/20 0.41
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 1/20 0.40
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 3/20 0.38
THRB P10828 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CCR1 P32246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3224732 0.80 NLRP3 (0.44) ALDH1A1NLRP3TSHRKMT2ASMN1; SMN2
SCHEMBL12499503 0.80 ALDH1A1 (0.44) ALDH1A1NLRP3TSHRKMT2AMEN1
SCHEMBL12499499 0.80 ALDH1A1 (0.44) ALDH1A1NLRP3TSHRKMT2AMEN1
SCHEMBL988882 0.80 TSHR (0.48) ALDH1A1NLRP3TSHRTDP1KMT2A
SCHEMBL17857571 0.80 ALDH1A1 (0.44) ALDH1A1NLRP3TSHRKMT2AMEN1
SCHEMBL29960754 0.79 ALDH1A1 (0.49) ALDH1A1TSHRKMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL8618217 0.78 IDO1 (0.44) ALDH1A1NLRP3TSHRKMT2ASMN1; SMN2
SCHEMBL6522396 0.78 SMN1; SMN2 (0.56) ALDH1A1NLRP3TSHRTDP1KMT2A
SCHEMBL8552393 0.78 MAPT (0.46) ALDH1A1KMT2ASMN1; SMN2GAAMAPT
SCHEMBL18726494 0.77 NLRP3 (0.46) ALDH1A1NLRP3TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5140040-A Alpha-2-adrenergic receptor antagonist; glaucoma; congestive heart failure; hypotensive agents; headaches; metabolic disorders (diabetes, obesity) ABBOTT LABORATORIES (US) 1992-08-18 US disclosed
US-5128362-A Antidepressant, antiglaucoma ABBOTT LABORATORIES (US) 1992-07-07 US disclosed
US-5086074-A Selective adrenergic receptor antagonists ABBOTT LABORATORIES (US) 1992-02-04 US disclosed